Search tool

Displaying 911 - 920 of 4575

Meeting on the risk assessment of the new psychoactive substance isotonitazene

The extended Scientific Committee of the EMCDDA meets on 26 May 2020 to examine the risk assessment by the EMCDDA on isotonitazene.

EMCDDA expert meeting

Satellite meeting - Annual meeting of the EMCDDA key indicator ‘Prevalence and patterns of drug use’ (GPS), online expert meeting for IPA beneficiaries

Because of the COVID-19 pandemic, some of the EMCDDA activities that were planned to take place between March and May this year have been adapted to an online format. This was the...

EMCDDA expert meeting

screenshot of page

COVID-19 resource page for people who use drugs (PWUD) and drug service providers

On this page, the EMCDDA has compiled examples of advice being issued to people who use drugs and service providers by some national bodies and different associations, networks and NGOs. This resource...

screenshot

Document library

Statement on risk of COVID-19 for people living with HIV (EACS & BHIVA )

Authors' summary: While there is so far no evidence for a higher COVID-19 infection rate or different disease course in people living with HIV (PLWH), many have socio-demopraphic charateristics as well as...

Drug-related infectious diseases in Europe: Update from the EMCDDA expert network, 2020

This 2020 EMCDDA update on drug-related infectious diseases aims to provide a comprehensive overview of the current situation with regard to the epidemiological picture of drug-related infectious diseases in Europe up to...

EMCDDA webinar: How is COVID-19 shaping the future of drug services in Europe?

The EMCDDA is offering a new series of webinars around the theme of COVID-19. The purpose of the webinars is to help those working in the drugs field understand how drug users...

Testing for drug-related infectious diseases — a crucial step towards meeting international health goals

Testing for drug-related infectious diseases among people who inject drugs (PWID) is crucial if international health targets are to be met. This is among the conclusions of a new EMCDDA report out...

Prevalence and patterns of drug use expert meeting 2020

19.05.2020 to 20.05.2020

The 2020 annual expert meeting on the EMCDDA epidemiological indicator ‘Prevalence and patterns of drug use among the general population’ (often referred to as the 'General population surveys indicator') takes place on-line...

EMCDDA expert meeting

Webinar: Closing the gaps on HIV self-testing/sampling in Lithuania and Italy

This webinar, integrated in the European Testing Week 2020, presents case examples from Lithuania (Asociacija Demetra) and Italy (Arcigay) where pilot activities were undertaken through the INTEGRATE JA to close the knowledge...

Document library

COVID-19 pandemic – National Rapid Guidance

At the request of the Government of Canada, CRISM is rapidly developing a series of six national guidance documents. Collectively, the six documents address urgent needs of people who use substances, service...